Transcript Highlights:

• Is there a difference between hospitals and private providers or clinics?
• Or is it just clinics?
• Nobody was as moved to fight for those clinics as they are to fight for hospitals.
• Because if not, you won't have a lot of primary care clinics. You'll have a lot of sicker people.
• Their recent meeting basically recommended the COVID vaccine for six months and up with shared clinical

Committee: House House Health & Human Services

Transcript Highlights:

• People will come walk into our clinic based on... Physically, they can't breathe.
• , ambulatory surgical centers, outpatient clinics, and birthing centers.
• , I represent myself as a direct primary care clinic.
• They're not getting any more referrals from my clinic as a result of that.
• clinical care.

Bills: SB331 , SB883 , SB926 , SB1137 , SB1138 , SB1144 , SB1151 , SB1236 , SB1270 , SB1522 , SB1869 , SB2207 , SB2422

Committee: Senate Health & Human Services

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Transcript Highlights:

• One quick example is our network of outpatient clinics.
• And you can see in here the red dots are where the clinics are located.
• Because over half the patients served in some of these clinics are uninsured, the clinics are not generating
• So what I would say is, I don't think clinical integration increases cost.
• So I do believe that clinical integration has a value.

Committee: Senate Health & Human Services

Keywords: 1185, senate, all

Transcript Highlights:

• </c> rigorously designed long-term clinical rigorously designed long-term clinical trials<00:36:52.960
• </c><00:43:30.480><c> rigor</c> to find a balance between clinical rigor to find a balance between clinical
• That stands for the Institute for Clinical and Economic Review.
• It takes this clinical approach for long-term benefits.
• </c> careful limitations, strict clinical careful limitations, strict clinical criteria,<01:13:48.159

Keywords: 958, all

Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.

Transcript Highlights:

• The clinic has to contact their insurance. It's a ding.
• They show up in our homes, in clinics, in communities long before They show up in our homes, in clinics
• clinic.
• clinic.
• We saw an abuser able to sue an abortion clinic, even though he drove his ex-wife to the clinic.

Keywords: 998, house, all

Transcript Highlights:

• I'm also a research fellow at the Massachusetts General Hospital and currently help lead a clinical trial
• As a biosimilar, Eucintech has been found to be as clinically effective as Stelara, As a biosimilar,
• To be approved as a biosimilar, a product must have no clinically meaningful differences in terms of
• From a clinical perspective, these are not optional.
• This bill helps turn clinical recommendations into real care. I urge you to support SB 1309.

Committee: Senate Health

Summary: The committee heard several health-related bills, beginning with SB 1124 on lung cancer screening awareness. The author and supporters said the bill would require CDPH signage about lung cancer screening eligibility at tobacco point-of-sale locations to address low awareness and low screening rates. Support came from medical students, physicians, and the California Academy of Family Physicians, while retailers raised concerns about sign size, retailer notification, and implementation. Committee members generally supported the bill and noted the need to work through those concerns. SB 1150 sought to require clearer patient notice when cancer cases are reported to the California Cancer Registry. The author described the bill as a response to inconsistent notification practices and privacy concerns, and the chair and other members shared personal stories about learning they or family members were in the registry without knowing it. Cancer registry and university stakeholders expressed appreciation for amendments but continued to have concerns or wanted more time to review the language. The bill was discussed as a patient-awareness measure rather than a change to reporting requirements. The committee also heard SB 1400 on Alameda Health System governance, SB 1094 on biosimilar substitution and health plan policies, SB 1314 on smoke shop regulation and nitrous oxide restrictions, and SB 1309 on eliminating cost-sharing for medically necessary follow-up after lung cancer screening. SB 1400 and SB 1314 drew support from local officials, labor, and public health advocates, with members emphasizing youth protection and local oversight. SB 1094 passed after extensive debate over pharmacist substitution authority and notification requirements, with a 6-0 vote and opposition from biotechnology and physician groups. SB 1309 also passed after members discussed the cost of follow-up care and the value of early detection, despite opposition from health plans over premium impacts; it received a 7-0 vote and was placed on call.

Transcript Highlights:

• When a professional title such as social worker or independent clinical social worker is used, the public
• or clinics that serve the underserved or independent pharmacies.
• This three-phase structure is drawn from the best practice in psychotherapy and other clinical trials
• While the clinical trials of psilocybin are showing extraordinary promise and outperforming currently
• Google because I wasn't really able to find anything through the wonderful people at the Mayo Clinic,

Bills: HF3454 , HF3917 , HF2906 , HF3832 , HF3769

Committee: House Health Finance and Policy

Keywords: social work, licensure, employment titles, health occupations, professional standards, medication repository, drug donation, healthcare, Minnesota Statutes, pharmacy, public health, controlled substances, psilocybin, psilocin, psychedelic, psychedelic medicine, hallucinogen, mushrooms, magic mushrooms, therapeutic use

Transcript Highlights:

• The Henry Ford Clinic in Michigan. No, I am not. 2,500 people were looking, were.
• By physicians and the Henry Ford Clinic. By doctors, yes.
• The Henry Ford Clinic then asked the Food and Drug Administration...
• A study from the Duke Clinical Institute found... Mr. Frank, for what purpose?
• In the bill analysis, the author only references its currently approved clinical uses.

Bills: HB25 , HB48 , HB149 , HB254 , HB26 , HB192 , HCR3 , HCR4 , HCR5 , HCR6 , HCR8 , HCR14 , HCR16 , HR1 , HR2 , HR3 , HR4 , HR6 , HR7 , HR8 , HR9 , HR12 , HR11 , HR13 , HR14 , HR15 , HR16 , HR20 , HR22 , HR23 , HR24 , HR25 , HR26 , HR27 , HR28 , HR29 , HR30 , HR31 , HR32 , HR33 , HR45 , HR48 , HR49 , HR51 , HR52 , HR55 , HR56 , HR57 , HR59 , HR60 , HR61 , HR62 , HR63 , HR64 , HR65 , HR66 , HR70 , HR71 , HR72 , HR74 , HCR2 , HCR7 , HR10 , HR21 , HR35 , HR36 , HR37 , HR38 , HR39 , HR40 , HR42 , HR43 , HR44 , HR46 , HR47 , HR50 , HR53 , HR54 , HR67 , HR69 , HR75 , HCR 5 , HCR 6 , HCR 8 , HCR 14 , HCR 16 , HR 1 , HR 3 , HR 4 , HR 6 , HR 7 , HR 8 , HR 9 , HR 12 , HR 11 , HR 13 , HR 14 , HR 15 , HR 16 , HR 20 , HR 22 , HR 23 , HR 24 , HR 25 , HR 26 , HR 27 , HR 28 , HR 29 , HR 30 , HR 31 , HR 32 , HR 33 , HR 45 , HR 48 , HR 49 , HR 51 , HR 52 , HR 55 , HR 56 , HR 57 , HR 59 , HR 60 , HR 61 , HR 62 , HR 63 , HR 64 , HR 65 , HR 66 , HR 70 , HR 71 , HR 72 , HR 74 , HCR 7 , HR 10 , HR 21 , HR 35 , HR 36 , HR 37 , HR 38 , HR 39 , HR 40 , HR 42 , HR 43 , HR 44 , HR 46 , HR 47 , HR 50 , HR 53 , HR 54 , HR 67 , HR 69 , HB 25 , HB 48 , HB 149 , HB 254 , HB 26 , HB 192

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, HB 48, Texas alert notification systems, emergency alerts, public warning systems, alert fatigue, notification fatigue, Texas Division of Emergency Management, Department of Public Safety, DPS alerts, emergency management, State of Texas Emergency Assistance Registry, STEAR, disaster notifications, weather alerts, Amber Alert

Transcript Highlights:

• </c> clinical outcomes researcher. clinical outcomes researcher.
• </c> comfort in the oh, it's past clinical comfort in the oh, it's past clinical one<01:22:46.840><c>
• It appears not to clinical trials.
• That drug entered the phase one clinical trials in the beginning of 2017, concluded phase one clinical
• That drug entered the phase one clinical trials in the beginning of 2017, concluded phase one clinical

Committee: Senate Health and Human Services

Keywords: 1191, senate, all

Transcript Highlights:

• I am a student at Florida State University earning my master's in clinical social work.
• I am a student at Florida State University earning my master's in clinical social work.
• I just have to think through the consequences of putting that onus on the adoption clinic or the pet
• So, but you brought up specifically, I think he said abortion clinics, which caught my attention.
• “So you were saying that line 70 to 72 somehow would bring in abortion clinics?”

Summary: The committee heard and voted on a long agenda of criminal justice, public safety, and civil justice bills. Among the measures reported favorably were SB 984, which adds aggravating factors for capital sentencing when a murder occurs during religious, school, or public government gatherings; SB 1140, creating a Hillsborough County pilot program to address substance abuse among offenders on probation; SB 1180, expanding child pornography laws to cover lewd altered or filtered images and solicitation; SB 10, providing compensation to Sidney Holmes for a wrongful conviction; SB 500, creating a Spectrum Alert system and training for missing children with autism; SB 1054, increasing penalties for tampering with electronic monitoring devices; SB 1072, establishing an expedited DNA testing grant program; and SB 240, the Haven Act, which aligns domestic and dating violence protections and creates a feasibility study for a discreet emergency contact system for victims. Several bills were amended before passage, including funding for the Spectrum Alert program and technical changes to the DNA, juvenile justice, and other proposals. Members also advanced SB 494, creating a statewide FDLE animal abuse database and increasing sentencing consequences for aggravated animal cruelty, with strong support from animal welfare groups and county officials. SB 1422 was reported favorably to strengthen penalties for unmanned aircraft over critical infrastructure and for weaponized drones, though members raised concerns about the bill’s “reasonable force” language. SB 1268 updated FDLE statutes and increased reimbursement for retired police dogs. SB 1252 was amended into a feasibility study for a statewide pawn data database, and SB 1386 increased penalties for assaults and batteries on utility workers, drawing support from utility and industry groups. The committee also approved SB 1084 on sexual cyber harassment, which criminalizes dissemination of intimate images and digitally forged intimate images, and SB 1654, which revises sexual offender and predator registration rules, including online reporting for certain in-state travel residences. SB 1650 expanded the vexatious litigant law, and SB 1652 created a public records exemption for stricken non-criminal court filings. Finally, SB 1284, expanding Florida’s Wrongful Death Act to allow civil claims for the death of an unborn child, drew extensive testimony both for and against; supporters called it a life-affirming measure, while opponents warned it could increase litigation, affect abortion-related care, and discourage physicians from practicing in Florida. The bill was heard with multiple public comments, but the transcript excerpt does not show a final vote on SB 1284.

Transcript Highlights:

• in any way we can help to bring more students, more interns, and not just in that area, there are clinics
• in Puerto Peñasco, medical clinics, that they bring some interns for doctors that are helping the people
• And my role has been organizing a clinic, a medical clinic, in one of the most underrepresented neighborhoods
• Still who participate in this clinic helping those who are most in need in the city of Rocky Point.
• And my role has been organizing a clinic, a medical clinic, and one of the most underrepresented neighborhoods

Bills: HB2746 , HB2751 , HB2752 , HB2753

Committee: House International Trade

Keywords: trade offices, committee, Arizona commerce authority, stakeholder input, efficiency, Arizona competes fund, economic development, fund repeal, state finances, state appropriations, Arizona Commerce Authority, job creation, business incentives, commerce authority, public-private partnership, business regulation, Arizona governance, 1182, all

Transcript Highlights:

• We have 14 hospitals, over 95 clinics, 18 retailies.
• We have 14 hospitals, over 95 clinics,<00:09:33.519><c> 18</c><00:09:33.839><c> retailies.
• </c><00:09:34.959><c> We</c><00:09:35.120><c> have</c><00:09:35.200><c> home</c> clinics, 18 retailies
• We have home clinics, 18 retailies.
• to prove it so that we can sustain this into the future through clinical understandings in how it is

Keywords: This meeting was pulled from back ups and uploaded in it's entirety due to technical issues., 958, all

Summary: The Make America Healthy Kentucky Task Force met with a quorum, approved the minutes, and then heard a presentation on the state’s “food is medicine” work from Kentucky Hospital Association and Kentucky Department of Agriculture leaders, including Jim Muser, Holly Harris, and Commissioner Jonathan Shell. The chair framed the discussion around personal wellness, injury prevention, and the broader goal of improving health through better sleep, nutrition, and activity, then asked the presenters to describe current initiatives and any policy changes needed. The witnesses described a partnership linking hospitals and Kentucky farmers to improve health outcomes while supporting rural agriculture. They said the effort has moved beyond the pilot stage and now includes more than 40 hospitals statewide, with programs such as healthier hospital cafeterias, grab-and-go options, farmers markets at hospital sites, subsidized CSA boxes for employees, and medically tailored meals or groceries for patients with chronic conditions. ARH was highlighted as a leading model, with local food procurement, employee wellness efforts, and measurable outcome pilots, including a Russell County Hospital project focused on diabetes, heart disease, and obesity. They also emphasized barriers to scaling the model, including fragmented short-term funding, lack of reimbursement for food-as-medicine programs, and burdensome procurement and testing requirements that can make it difficult for small farmers to participate. The presenters said hospitals are using their own funds or temporary grants to sustain programs and argued that policy changes are needed to simplify sourcing, expand reimbursement pathways, and support clinical measurement of outcomes. No votes or formal actions beyond approving the minutes were taken during the portion provided.

Transcript Highlights:

• relating to veterinary recruitment and retention and creation of an ectoparasite field identification. laboratory
• network, which again, that's the fancy word for weather stations, and the expansion of the materials laboratory

Committee: House Appropriations - S/C on Articles VI, VII, & VIII

Keywords: 1184, house, all

Transcript Highlights:

• Fourth was the Clinical Infrastructure Program, $20 million.
• annually. clinic sites and serve 6.2 million Californians annually.
• At the time, the county operated 11 county clinics with program and clinic staff of about 150.
• We're already talking about cutting two clinics.
• Well, I've been to both your clinics.

Keywords: 988, house, all

Transcript Highlights:

• The clinics, the hospital, everywhere there's impact because of what is taking place.
• Okay, so clinics to help with the Medicare. Correct. So, but not a lot of with the CalFresh.
• It's only those who go to clinics. They're going to get additional navigation services?
• This particular grant program is through the clinics, yes. Okay.
• We'll have a community mental health clinic keep a patient stable throughout treatment.

Summary: The Senate Budget and Fiscal Review Subcommittee held an oversight hearing on the impacts of H.R. 1 on California’s safety net, focusing on Medi-Cal and CalFresh. The chair and vice chair framed the issue as a major federal disruption that would reduce benefits and shift costs to the state, counties, hospitals, and other local systems. The first panel included the Legislative Analyst’s Office, the Department of Finance, the UC Berkeley Labor Center, and the Food Research and Action Center, each describing projected enrollment losses, higher state and county costs, and implementation challenges. The LAO outlined H.R. 1’s main changes: new and expanded work requirements, more frequent eligibility redeterminations, restrictions on certain non-citizen eligibility, and financing changes affecting provider taxes and federal matching rates. The LAO estimated that 1 to 2 million people could be disenrolled from Medi-Cal and more than 600,000 could lose CalFresh, with additional costs from reduced federal support and possible state and county administrative burdens. The Department of Finance said the Governor’s budget includes about $1.4 billion General Fund in 2026-27 to respond to H.R. 1, with larger out-year reductions in federal funds and projected Medi-Cal caseload losses of up to 2 million by 2029-30. The UC Berkeley Labor Center projected up to 3 million Californians could lose full-scope Medi-Cal by 2028 when H.R. 1 is combined with state budget changes, while noting the state could choose policies that would reduce some of those losses. The Food Research and Action Center warned that CalFresh cuts and time limits would increase hunger, worsen health outcomes, and strain local economies and emergency systems. Members questioned the witnesses about procedural disenrollments, regional variation, the overall growth in Medi-Cal spending, the future of the MCO tax, the CalFresh error rate, and the downstream effects on hospitals and county indigent care. Several senators argued that the federal law was driven by tax cuts for high-income earners and would disproportionately harm low-income Californians, immigrants, and communities of color. Administration witnesses said some impacts are still being analyzed, that counties and departments are working on implementation, and that the Legislature may need to use statute, reporting, and oversight tools as federal guidance develops. No votes or formal actions were taken during this portion of the hearing.

Transcript Highlights:

• And then coming soon is again another model for the community-based behavioral health clinics.
• They're with the Suquamish Tribe and Kitsap OBGYN clinic.
• In 2023, our Keeling House Medical Clinic opened to the tribal and non-tribal community, adding primary
• Bill, Health guidelines align clinical care with population health through Senate Bill 5602, and we
• Katie, I would just underscore what you mentioned about clinical data: information that comes from the

Summary: The Senate Health and Long-Term Care Committee met on July 30, 2026, to hear two main briefings. The first, from the Health Care Authority, focused on implementation of federal H.R. 1 Medicaid changes and Washington’s rural health transformation funding. HCA said the state is preparing for major eligibility changes, including the October 1 loss of Medicaid coverage for about 14,000 lawfully present non-citizens and January 1, 2027 work requirements, six-month renewals, and reduced retroactive coverage for roughly 600,000 Medicaid expansion adults. Officials described outreach efforts, new automated verification systems, a verification hub, and plans to use available data sources to reduce manual paperwork, while noting that about one-third of the affected population may still need manual processing. They also said H.R. 1 will limit state-directed payments over time, with an estimated long-term impact of up to $1.5 billion in hospital reimbursements. On rural health transformation, HCA said it is moving quickly to obligate its $181 million federal award through contracts and competitive grants for rural hospitals, workforce, behavioral health, technology, and tribal and community partners. Committee members asked about the impact on rural providers, community service as a work-requirement pathway, emergency Medicaid, tribal and federal reimbursement issues, and whether the state would submit comments on the federal work-requirement rule. HCA said it would file comments, that emergency Medicaid coverage for certain services remains available, and that it is working with tribes and other agencies to avoid erroneous terminations and to move eligible people into other coverage where possible. Members also raised concerns about the administrative burden on families and providers and the need for congressional attention on issues such as TRICARE reimbursement. The second briefing addressed maternal health and the Department of Health’s Maternal Mortality Review Panel report. DOH said maternal mortality in Washington increased for the first time in the report series, but most pregnancy-related deaths remain preventable. Nearly half were linked to behavioral health conditions, especially overdose deaths, with suicide, cardiovascular disease, and COVID-19 also significant causes; most deaths occurred postpartum rather than during delivery. The report found higher mortality rates among American Indian and Alaska Native, Black, Native Hawaiian, Pacific Islander, multiracial, rural, and Medicaid-covered populations, and identified lack of access to care, financial hardship, housing instability, discrimination, bias, and systemic inequities as major contributors. DOH highlighted existing state actions such as one-year postpartum coverage, doula reimbursement, inpatient substance use treatment coverage for birthing people, and vaccine coverage requirements, and offered 12 legislative recommendations focused on affordable and high-quality care, basic needs and community supports, and equitable, culturally responsive services. Presenters from the Suquamish Tribe and Kitsap OBGYN described how the tribe acquired and stabilized a threatened OB-GYN practice to preserve regional access amid provider shortages and hospital service losses. They said rural obstetric care is difficult to sustain because of thin margins, workforce shortages, long travel distances, and higher-risk patients, and emphasized that tribal health systems can offer stronger reimbursement and integrated family-centered care. The Foundation for Healthcare Quality and the Bree Collaborative then outlined statewide maternity-care quality efforts, including work on perinatal behavioral health, care coordination, postpartum screening, doula support, and better-aligned payment models. They said Washington has strengths in innovation but still needs more OB-GYN capacity, better transitions of care, and more culturally responsive, trauma-informed maternal and Native health services.

Transcript Highlights:

• Fortunately, lower-cost alternatives like generics or biosimilars offer the same clinical result as their
• I’m a licensed clinical social worker at the California Department of Corrections. I’m in support.
• It's fundamentally clinical, and I get that.
• But it's clinical.
• It is clinical, yes, but it is emotional.

Summary: The committee heard several bills, beginning with SB 1312 by Senator Richardson on abandoned endowed-care cemeteries. Richardson described vandalism, theft, and neglect at abandoned cemeteries and said the bill would define abandonment, create a process for local governments to declare a cemetery abandoned, and allow the Bureau to act as conservator of endowment funds. Support came from Marin County, while county and special district groups opposed or had concerns, arguing the bill could shift burdens to local governments or public cemetery districts without enough safeguards. Members expressed general support but noted the need for further work; the bill was discussed but no final vote was taken in the excerpt. The committee then took up SB 758 by Senator Umberg, which would restrict retail sales of nitrous oxide to curb misuse. Supporters, including the League of California Cities, narcotic officers, counties, pediatricians, and other local governments and health groups, said easy access at smoke shops and convenience stores has fueled recreational abuse and health harms. There was no opposition testimony, and members voiced strong support for a statewide approach over city-by-city bans. The bill was well received, with the author closing in support. Dr. Weber-Pierson presented SB 1094, a health care affordability bill on biosimilars and biologic substitution. The bill would allow pharmacists to substitute biosimilars under certain conditions, require advance notice to providers and patients, and add reporting on savings; the author said amendments would strengthen provider notice and preserve the ability to mark prescriptions “do not substitute.” Supporters from health plans, insurers, pharmacies, labor, business, and some provider groups argued the bill would lower costs and expand access. Opponents, including dermatology and rheumatology groups and biotech interests, warned about non-medical switching, prior authorization delays, and patient harm. After extensive discussion, the committee voted 13-0 to pass SB 1094 to the Committee on Health. The committee also passed SB 849 by Dr. Weber-Pierson, which would bar reinstatement of physicians who surrendered their licenses while a sexual misconduct accusation was pending. The Medical Board and California Medical Association were generally supportive or neutral, and members praised the bill’s patient-protection focus. SB 993 by Senator Ochoa Bogh, which limits routine disclosure of identifying information for mental health professionals in correctional and psychiatric settings while preserving complaint processes, also passed unanimously to Appropriations. SB 1002 by Senator Niello, extending the David Hall Act to allow certain patients in remission to continue telehealth care with out-of-state specialists, drew strong patient support but opposition from the Medical Board and CMA over licensure and oversight concerns; the committee voted it out on a split roll with some members not voting. Finally, SB 1263 by Senator McGuire, aimed at protecting wildfire survivors and workers by requiring licensed, trained contractors for post-disaster residential debris removal, received support from labor and the Contractors State License Board, with contractors raising a narrower amendment concern about scope.

Transcript Highlights:

• I'm a licensed clinical social worker by trade.
• They enhance support or serve as an alternative to clinical treatment.
• Peers are non-clinical, so they do not assess or diagnose.
• This is embedded in the outpatient clinics and the three providers that have outpatient clinics.
• It doesn't need to be, the service doesn't need to happen in the outpatient clinic.

Keywords: 962, all

Summary: The meeting opened with approval of the April minutes and brief administrative updates, including notice that House Bill 5447 had passed both chambers of the General Assembly. Speakers reflected on the bill’s key provisions, which include eating-disorder working groups, an evidence-based screening requirement for school-based health centers beginning July 1, 2027, and a DSS-led feasibility process to explore an inpatient psychiatric facility for young adults ages 14 to 21. New staff introductions were also made for the Behavioral Health Advocate’s office and the TCB team. A major portion of the meeting focused on marketing and outreach for urgent crisis centers (UCCs) and the broader youth crisis continuum. Daydream Communications presented research showing low public awareness of UCCs but strong interest once families learn about them, with parents wanting specialized, compassionate care, clear expectations, insurance clarity, and bilingual support. United Way described its parallel work on a statewide crisis continuum marketing toolkit, using the SAMHSA framework of “someone to talk to, someone to respond, and somewhere safe to go,” and outlined plans to distribute consistent messaging through websites, social media, flyers, and community venues. Members emphasized coordinating with existing platforms and ensuring the marketing reflects the actual experience at UCC sites. DCF then presented on adolescent substance use services, citing data showing high need and low treatment access among Connecticut youth. The department reviewed its ASAM-based continuum, SBIRT efforts in outpatient psychiatric clinics, medication-assisted treatment access, and statewide services such as MST, MST emerging adults, STRIDE, multidimensional family therapy, youth recovery supports, and the AIM matching tool. A new young people peer support program was highlighted, with referrals accepted from families, hospitals, community providers, DCF, youth diversion, and the judicial branch. Questions addressed parent consent, peer matching, and whether the AIM tool could be linked through 211. The meeting concluded with an update from the Connecticut Suicide Advisory Board and its regional boards and grant-funded initiatives. Presenters reviewed the state suicide prevention plan, regional coalition work, postvention response, lethal means safety efforts, and the 988 capacity improvement grant that supports Connecticut’s centralized 988 contact center at United Way. They also shared youth suicide risk data from the Connecticut Youth Risk Behavior Survey, noting recent declines in reported suicidal ideation and attempts, and provided resources for training and materials. No formal votes were taken beyond the approval of the April minutes.

Transcript Highlights:

• Health Care Authority’s decision package to fund at least two certified community behavioral health clinics
• We are trusted by youth and families in a different way because our services are not clinical and we
• The RHCs maintained dental clinics to provide in-house dental care to residents.
• These clinics are built, they're licensed, and most importantly, they're already staffed.
• They serve those folks over at the dental clinic or send them out to local hospitals.

Summary: The committee began with a work session on recommendations from the Children and Youth Behavioral Health Work Group. Tisha Kirshbaum of the Health Care Authority described the Washington Thriving Strategic Plan, a prenatal-to-25 system-of-care framework meant to reduce fragmentation, improve coordination across multiple state agencies, and expand early, community-based behavioral health supports. Members asked about duplication among agencies, simplification of the system, and upstream services such as community health workers, school-based supports, and crisis access. The committee then heard House Bill 2429, which would direct the governor and state agencies to align with the Washington Thriving plan, create an executive coordination officer and leadership council, extend the work group, and require broader alignment by state, tribal, local, and nonprofit entities. The bill received strong support from the governor’s office, the Health Care Authority, parents, youth, providers, and advocates, while a few testifiers raised concerns about government overreach, cost, or the need to address non-psychiatric causes of distress. No vote was taken during the hearing. The committee then heard House Bill 2364, which renames and expands the Legislative Executive Work First Poverty Reduction Oversight Task Force into the Legislative Executive Economic Justice and Well-Being Task Force and updates the related advisory council to align with the state’s 10-year plan to dismantle poverty. Staff and the prime sponsor said the bill reflects the evolution of the poverty-reduction effort and adds agencies such as the Department of Revenue, Health Care Authority, and Workforce Training and Education Coordinating Board. Testimony from DSHS and advocates was uniformly supportive, emphasizing bipartisan collaboration and the need to update statute to match current work. Next, the committee heard House Bill 2171 on supporting foster youth. The bill would create an endangered foster youth alert system, require county rapid-response protocols, establish a foster youth empowerment account, create an oversight board through the Ombuds office, and expand training for foster parents and child welfare workers. The prime sponsor and several advocates described the bill as a response to lived experience and a way to improve accountability and long-term support. DCYF said it supports the intent but raised legal and cost concerns, and some youth advocates warned that public alerts could increase risk or trauma for youth who run away from unsafe placements. The hearing then moved to House Bill 2314, which would create a pilot allowing certain community-based clients with developmental disabilities to receive dental care at residential habilitation centers. Supporters said the bill would use existing dental capacity to address severe access gaps and long waits in the community, while opponents from disability advocacy groups argued it would pull people back into institutional settings instead of building community-based dental capacity. Testimony on the bill was mixed, and no final committee action was taken in the transcript.

Transcript Highlights:

• The agency operates four clinics in South Texas and one mobile health unit.
• This is my 12th year working with TMHP provider enrollment to credential our clinic. ...I've asked the
• I practiced for 17 years as a clinical pharmacist and hospital pharmacist, as a licensed pharmacist.
• So there's a five percent chance when you're at phase one clinical trial.
• Arena on that side, they're more medical, more clinical, more scientist-related and this bill doesn't

Bills: SB623 , SB1266 , SB1310 , SB1373 , SB1580 , SB1952 , SB2032 , SB2269 , SB2544 , SB2653 , SB2796

Committee: Senate Health & Human Services

Keywords: pharmacist, vaccine administration, COVID-19, exclusive authority, healthcare, Medicaid, provider enrollment, credentialing, administrative burden, Texas Health and Human Services, senior retirement communities, emergency response, residential safety, contract provisions, health and safety regulations, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges